JSF Financial LLC Trims Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• JSF Financial LLC has reduced its stake in UnitedHealth Group by 28.2%, now holding shares valued at $1.45 million.
• UnitedHealth Group increased its dividend to $2.21 per share, up from $2.10, resulting in an annualized yield of 3.13%.
• The stock has seen varied analyst ratings, with target prices ranging from $270.00 to $563.00, indicating a consensus rating of "Moderate Buy".

JSF Financial LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 28.2% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,762 shares of the healthcare conglomerate's stock after selling 1,086 shares during the quarter. JSF Financial LLC's holdings in UnitedHealth Group were worth $1,446,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of UNH. Geode Capital Management LLC increased its stake in shares of UnitedHealth Group by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate's stock valued at $10,068,869,000 after buying an additional 319,515 shares in the last quarter. Capital International Investors boosted its holdings in UnitedHealth Group by 6.2% during the fourth quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock worth $7,899,905,000 after buying an additional 906,365 shares during the last quarter. Northern Trust Corp boosted its holdings in UnitedHealth Group by 12.5% during the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after buying an additional 1,058,488 shares during the last quarter. Franklin Resources Inc. lifted its holdings in shares of UnitedHealth Group by 10.7% during the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate's stock valued at $4,514,178,000 after purchasing an additional 861,854 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after purchasing an additional 2,301,010 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on UNH. Royal Bank Of Canada dropped their target price on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday. Erste Group Bank lowered UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Piper Sandler lowered their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research report on Wednesday. JPMorgan Chase & Co. boosted their price target on UnitedHealth Group from $405.00 to $418.00 and gave the stock an "overweight" rating in a research report on Friday, June 20th. Finally, Hsbc Global Res lowered UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $373.52.

UnitedHealth Group Trading Down 4.9%

NYSE UNH traded down $12.28 during trading hours on Friday, hitting $237.28. 27,115,155 shares of the company's stock were exchanged, compared to its average volume of 11,900,368. The stock has a 50-day simple moving average of $298.02 and a 200 day simple moving average of $418.35. UnitedHealth Group Incorporated has a 1-year low of $235.70 and a 1-year high of $630.73. The firm has a market cap of $215.25 billion, a price-to-earnings ratio of 10.28, a PEG ratio of 1.54 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The firm's revenue was up 12.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $6.80 EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a $2.21 dividend. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.7%. The ex-dividend date was Monday, June 16th. UnitedHealth Group's dividend payout ratio is 37.02%.

Insider Buying and Selling

In other UnitedHealth Group news, CFO John F. Rex purchased 17,175 shares of the company's stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the acquisition, the chief financial officer owned 203,796 shares of the company's stock, valued at $59,329,091.52. The trade was a 9.20% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Stephen J. Hemsley bought 86,700 shares of the stock in a transaction on Friday, May 16th. The stock was purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the purchase, the chief executive officer owned 679,493 shares of the company's stock, valued at approximately $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.